Adults using a GLP-1 had an increase in GFR from 50.48 mL/min/1.73 m 2 at baseline to 53.44 mL/min/1.73 m 2 at 6 months, whereas the control group had a decrease from 43.4 mL/min/1.73 m 2 at baseline to 40.84 mL/min/1.73 m 2 at 6 months ( P = .03)
This is part of why peptides have drawn attention for cognitive and mood concerns
FLOW Analysis: Semaglutide Delivers Consistent Kidney Benefit in T2D/CKD Across CVD Status Semaglutide improved kidney and survival outcomes in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD), including those with established atherosclerotic cardiovascular disease (ASCVD), heart failure (HF) and high total cardiovascular disease risk, according to a subgroup analysis of the FLOW trial published June 2 in JACC
Serious hypersensitivity reactions, including anaphylaxis, laryngeal edema, and bronchospasm have been reported following levocarnitine administration, mostly in patients with end stage renal disease who are undergoing dialysis
Made in the EU: Scitec Nutrition products are made in the EU
Formule Exclusive SDM
